Stay updated with breaking news from Hellen Kim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results - read this article along with other careers information, tips and advice on BioSpace
Soligenix: Phase III Trial Success Offers New Hope to Those Living with Rare Disease
Shining a Light on a New Hope for a Rare Form of Non-Hodgkins Lymphoma: Conversation with Dr. Ellen Kim on HyBryte™ from Soligenix July 06, 2021 15:39 ET | Source: PCG Digital PCG Digital New York, NY, July 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- PCG Digital -- A rare form of non-Hodgkin’s lymphoma, cutaneous T-cell lymphoma (CTCL) has no current FDA-approved first-line therapies. There are roughly 3,000 new CTCL cases in the United States each year, with more than 20,000 patients living with CTCL. Small cap biotech Soligenix (Nasdaq: SNGX) is develop...
Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results News provided by Share this article Share this article PRINCETON, N.J., May 17, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2021. "This year continues to be an exciting year of progress for Soligenix," stated Christopher J. Schabe...
Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meeting News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Ellen Kim, MD, Medical Director, Dermatology Clinic, Perelman Center for Advanced Medicine, Professor of Dermatology at the Hospital of the Uni...